Search results
Minnesota Vikings reportedly bring back guard Dalton Risner
CBS News· 5 days agoThe Minnesota Vikings are reportedly bringing back Dalton Risner, last year's starting left guard,...
Amy Homma succeeds Jacqueline Stewart to lead Academy Museum
CW39 NewsFix· 5 days agoJacqueline Stewart is leaving her post leading the Academy Museum of Motion Pictures to return to...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 17 hours ago-- CB-010 allogeneic CAR-T cell therapy with partial HLA matching has potential to rival efficacy and safety profile of approved autologous CAR-T cell therapies -- -- 14.4 months median PFS in ANTLER patients with partial HLA matching (≥4 alleles
1 arrested, 1 injured in wreck Monday morning in downtown Amarillo
KAMR Amarillo· 7 days agoAMARILLO, Texas (KAMR/KCIT) — The Amarillo Police Department reports that one man was arrested and a...
Students spread positivity through Calgary mural project
KLAX-TV· 2 days agoWith dozens of different messages of positivity, students at Tom Baines School in northwest Calgary...
Minnesota launches summer EBT program for families with school-aged kids
CBS News· 3 days agoGov. Tim Walz on Thursday announced a new way to help low income families with school-aged kids buy...
Celebrating Joyce Garbaciak as she steps away from WISN 12 News anchor desk
WISN 12 Milwaukee· 6 days agoShe will anchor her final newscast Friday, May 31
Rapper Sean Kingston agrees to return to Florida, where he and mother are charged with $1M in fraud
WOI-TV Des Moines· 5 days agoThe arrest warrants allege Kingston and his 61-year-old mother stole money, jewelry, a Cadillac...
What happens if you tie in a Texas runoff election?
KAMR Amarillo· 5 days agoWhen elections are held in Texas, there are times in which nobody in the running for a particular office gets the majority of votes needed to win. Runoff...
Rgenta Therapeutics Presents Preclinical Data from Lead Program RGT-61159, a Potent Inhibitor of...
The Woonsocket Call· 3 days agoRgenta Therapeutics, a biotechnology company pioneering the development of a new class of oral small molecules for therapeutic RNA modification for oncology and CNS disorders, today announced ...
